Expression of apoptosis-related proteins and morphological changes in a rat tumor model of human small cell lung cancer prior to and after treatment with radiotherapy, carboplatin, or combined treatment

Virchows Archiv

Volumn 442, Issue 4, 2003, Pages 349-355

  Fokkema, E ^a   De Vries, E G E ^a   Groen, H J M ^a   Meijer, C ^a   Timens, W ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Apoptosis; Platinum resistance; Rat; Small cell lung cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; EOSINE BLUE; FAS ANTIGEN; HEMATOXYLIN; MYC PROTEIN; PARAFFIN; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER; CANCER SURGERY; CANCER THERAPY; CELL HETEROGENEITY; CELL SIZE; CELL STRUCTURE; CHEMOTHERAPY; CLINICAL PATHWAY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SENSITIVITY; GIANT CELL; HINDLIMB; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; MEDICAL ASSESSMENT; MORPHOLOGY; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION RESPONSE; RAT; TUMOR CELL; TUMOR MODEL;

EID: 0038026059     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-003-0763-9     Document Type: Article

References (25)

1. Adelstein DJ, Lavertu P, Saxton JP, Secic M, Wood BG, Wanamaker JR, Eliachar I, Strome M, Larto MA (2000) Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 88:876-883
2. Bracey TS, Williams AC, Paraskeva C (1997) Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function. Clin Cancer Res 3:1371-1381
3. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Bertrand P (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081-2086
4. Cheng SH, Tsai SY, Yen KL, Jian JJ, Chu NM, Chan KY, Tan TD, Cheng JC, Hsieh CY, Huang AT (2000) Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma. J Clin Oncol 18:2040-2045
5. Dewey WC, Ling CC, Meyn RE (1995) Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 33:781-796
6. Groen HJM, Sleijfer S, Meijer C, Kampinga HH, Konings AW, de Vries EGE, Mulder NH (1995) Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines. Br J Cancer 72:1406-1411
7. Groen HJM, van der Leest AHD, Snoek WJ, Nossent B, Oosterhuis B, Nabers H, Smit WJGM, Timmer PR, Otter R, van Putten JWG, Fokkema E, Hoekstra HJ, Hermans J, Szabo BG, de Vries EGE, Mulder NH (1999) Phase III study of continuous carboplatin over 6 weeks with radiation versus radiation alone in stage III non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 17:466a
8. Hendrikse NH, de Vries EGE, Eriks-Fluks L, van der Graaf WTA, Hospers GAP, Willemsen AT, Vaalburg W, Franssen EJ (1999) A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier. Cancer Res 59:2411-2416
9. Hickman, JA (1992) Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11:121-139
10. Hospers GAP, Mulder NH, de Jong B, de Ley L, Uges DRA, Fichtinger-Schepman AMJ, Scheper RJ, de Vries EGE (1988) Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro. Cancer Res 48:6803-6807
11. Hospers GAP, Meijer C, de Leij L, Uges DRA, Mulder NH, de Vries EGE (1990) A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance. Int J Cancer 46:138-144
12. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, Walker JL, Gersell D (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154-1161
13. Leonhardt EA, Trinh M, Forrester HB, Dewey WC (1998) Persistent decrease in viability as a function of X irradiation of human bladder carcinoma cells in G1 or S phase. Radiat Res 149:343-349
14. Los G, Verdegaal EM, Mutsaers PH, McVie JG (1991) Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy. Cancer Chemother Pharmacol 28:159-165
15. Los G, Smals OAG, van Vugt MJH, van der Vlist M, den Engelse L, McVie JG, Pinedo HM (1992) A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity. Cancer Res 52:1252-1258
16. Meijer C, Mulder NH, Hospers GAP, Uges DRA, de Vries EGE (1990) The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br J Cancer 62:72-77
17. Meijer C, Mulder NH, Timmer-Bosscha H, Sluiter WJ, Meersma GJ, de Vries EGE (1992) Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Cancer Res 52:6885-6889
18. Peled A, Schwartz D, Elkind NB, Wolkowicz R, Li R, Rotter V (1996) The role of p53 in the induction of polyploidity of myelomonocytic leukemic M1/2 cells. Oncogene 13:1677-1685
19. Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949-955
20. Reed JC (1999) Dysregulation of apoptosis in cancer. J Clin Oncol 17:2941-2953
21. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144-1153
22. Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326:524-530
23. Trovo MG, Minatel E, Franchin G, Gobitti C, Roncadin M, De Paoli A, Arcicasa M, Boz G, Bortolus R (1992) Radiotherapy enhanced by cis-platinum in stage III non-small cell lung cancer: a phase II study. Radiother Oncol 23:241-244
24. Vokes EE, Kies MS, Haraf DJ, Stenson K, List M, Humerickhouse R, Dolan ME, Pelzer H, Sulzen L, Witt ME, Hsieh YC, Mittal BB, Weichselbaum RR (2000) Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 18:1652-1661
25. Wouters BG, Giaccia AJ, Denko NC, Brown JM (1997) Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res 57:4703-4706